Pilot Study of AVT16 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

November 6, 2024

Study Completion Date

November 6, 2024

Conditions

Healthy

Interventions

BIOLOGICAL

AVT16

Single intravenous administration of 300mg of AVT16

Trial Locations (1)

CCST, Christchurch

All Listed Sponsors

lead

Alvotech Swiss AG

INDUSTRY

NCT06400719 - Pilot Study of AVT16 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter